American Century Companies
OKUR

American Century Companies’s OnKure Therapeutics OKUR Stock Holding History

American Century Companies’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,823
Closed -$30.3K – 2964
2024
Q1 		$30.3K Hold
1,823
– – ﹤0.01% 2915
2023
Q4 		$29.2K Buy
+1,823
New +$114K ﹤0.01% 2865

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

American Century Companies's OKUR Position: Q2 2024 in Review

American Century Companies sold out of OnKure Therapeutics (OKUR) in Q2 2024, closing a stake of 1,823 shares — an estimated $30.3K sold.

American Century Companies first reported a position in OKUR in Q4 2023 and held it in 2 quarters. The position peaked at $30.3K in Q1 2024. 66 funds tracked by Wall St. Rank hold OKUR as of Q2 2024.

  • American Century Companies reported no remaining OnKure Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American Century Companies sold 1,823 OnKure Therapeutics shares in Q2 2024, an estimated $30.3K.
  • American Century Companies first reported a position in OnKure Therapeutics in Q4 2023 and held it in 2 quarters.
  • American Century Companies's OnKure Therapeutics position peaked at $30.3K in Q1 2024.
  • 66 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2024.

Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.